NUR 635 Topic 2 antimicrobial selection rationale example

Advanced Pharmacology Grand Canyon University Free custom sample in 24 to 48h

This NUR 635 Topic 2 sample paper justifies three drugs started at once for bacterial meningitis in Mr. S., a composite 58-year-old who arrived confused after 18 hours of fever, headache and neck stiffness. It belongs to GCU NUR 635, Advanced Pharmacology, listed as NUR-635, part of Grand Canyon University's MSN. The likely organisms are named first. Ceftriaxone, vancomycin and ampicillin are each chosen against an organism, with dexamethasone before the first dose. Doses are justified against the blood-brain barrier. Intravenous therapy is kept with no oral switch. Cultures grow pneumococcus at 36 hours, so therapy narrows on day 3. A stopping date at day 14 follows Tunkel and colleagues, with de Gans and van de Beek.

CourseNUR 635 Advanced Pharmacology
TopicTopic 2
Paper typeAntimicrobial selection rationale
LengthAbout 970 words, 4 pages
FormatAPA 7 student paper
SchoolGrand Canyon University (GCU)
ProgramMSN
UpdatedOctober 2026

Free sample paper for NUR 635 Topic 2

1

Three Drugs Tonight, One by Day 3, Stop on Day 14: An Antimicrobial Selection Rationale for Community-Acquired Bacterial Meningitis in a 58-Year-Old Man

[Author Name]

College of Nursing and Health Care Professions, Grand Canyon University

NUR-635: Advanced Pharmacology

Topic 2 Assignment

[Instructor Name]

January 21, 2030

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

What this page is doingThe title states the whole prescribing arc, broad start, planned narrowing and a stopping date, before the reasoning begins. The patient and results are a composite written for teaching.
2

Three Drugs Tonight, One by Day 3, Stop on Day 14: An Antimicrobial Selection Rationale for Community-Acquired Bacterial Meningitis in a 58-Year-Old Man

The Infection, the Likely Organisms and the Patient

Mr. S., a composite 58-year-old man weighing 76 kg, arrived at the emergency department with 18 hours of fever, severe headache and neck stiffness, and was confused, with a Glasgow Coma Scale score of 13. He has no rash, no recent head injury or neurosurgery and no immune suppression; his creatinine is 0.9 mg/dL, and he reports no drug allergies, which was confirmed with his wife and his pharmacy record. Blood cultures were drawn and a lumbar puncture performed without delay. The cerebrospinal fluid showed an opening pressure of 38 cm of water, 2,400 white cells per microliter with 90 percent neutrophils, protein 280 mg/dL and glucose 18 mg/dL with a serum glucose of 110. The Gram stain showed no organisms. This is acute bacterial meningitis until proven otherwise.

In an adult of his age with community-acquired meningitis, the likely organisms are Streptococcus pneumoniae, by far the most common, Neisseria meningitidis and, because he is over 50, Listeria monocytogenes (van de Beek et al., 2021). Local resistance matters for the first of these: the hospital's antibiogram last year showed 4 percent of invasive pneumococcal isolates nonsusceptible to ceftriaxone at the meningitis breakpoint. A negative Gram stain does not narrow the list, because the stain misses a substantial share of cases.

What this page is doingThe organisms and the patient factors that shape them are named before any drug. The coverage requirement comes from this list, so the agents in the next section follow from the reasoning rather than preceding it.
3

The Agents, Chosen Against the Coverage Requirement

Three agents are started together, each for a named organism (Tunkel et al., 2004). Ceftriaxone covers S. pneumoniae and N. meningitidis. Vancomycin is added because of the small but real chance that the pneumococcus is resistant to ceftriaxone; if it were, ceftriaxone alone would fail in a space where failure means death or permanent disability. Ampicillin is added for Listeria, which is intrinsically resistant to all cephalosporins, so ceftriaxone and vancomycin together would leave it untreated.

This regimen is deliberately broad, and the breadth is a cost accepted for a defined period: vancomycin and ampicillin buy certainty against two organisms that are each unlikely in this patient, and they are paid for in kidney risk, drug exposure that selects for resistance and disruption of the gut flora, so each is started with the specific result that would stop it already named. The regimen deliberately does not cover gram-negative rods such as Pseudomonas, which are not expected in community-acquired meningitis without neurosurgery or trauma, or herpes simplex virus; acyclovir was not added because the fluid's neutrophil count, protein and low glucose make a bacterial cause far more likely, and it would be reconsidered if cultures stay negative.

Dexamethasone, 10 mg intravenously every 6 hours, was given 15 minutes before the first antibiotic dose. In adults with bacterial meningitis, early dexamethasone reduced the risk of an unfavorable outcome, and among patients with pneumococcal meningitis, unfavorable outcomes fell from 52 percent with placebo to 26 percent (de Gans & van de Beek, 2002).

Dose and Interval, Justified Against the Site

Meningitis requires doses that would be excessive for infection elsewhere, because the drug must cross the blood-brain barrier into cerebrospinal fluid, where concentrations reach only a fraction of those in blood, even with inflamed meninges. Ceftriaxone is given at 2 g every 12 hours, twice the total daily dose used for pneumonia. Ampicillin is given at 2 g every 4 hours, 12 g a day, since its half-life is only about an hour and its killing depends on time above the organism's inhibitory concentration. Vancomycin is given as a loading dose of 25 mg/kg, about 1,900 mg, then 15 mg/kg every 8 hours, adjusted by serum concentrations, because penetration into cerebrospinal fluid is poor and variable. His normal kidney function allows full doses; creatinine is checked daily while he receives vancomycin, and vancomycin and ampicillin doses would be reduced if it rose.

Route

All three are given intravenously, and the stated criterion for an oral switch is that there is none for this infection: no oral agent achieves reliable cerebrospinal fluid concentrations against these organisms, so the whole course remains parenteral. Once he is clinically stable, afebrile and eating, the remaining course of ceftriaxone can be completed at home through a peripherally inserted central catheter, which changes the setting but not the route.

What Happened on Day 2, and De-escalation

Blood and cerebrospinal fluid cultures grew S. pneumoniae at 36 hours. Susceptibility testing reported a ceftriaxone inhibitory concentration of 0.25 mg/L, susceptible at the meningitis breakpoint, and penicillin resistant at the meningitis breakpoint. The de-escalation plan, written on admission, specified that a pneumococcus susceptible to ceftriaxone would end both vancomycin and ampicillin, and that is what happened on day 3: ceftriaxone 2 g every 12 hours continues alone. Penicillin is not used because this isolate is resistant at the level that matters for cerebrospinal fluid. Dexamethasone continues for the full four days because the organism is pneumococcal. The infectious diseases pharmacist and the admitting physician reviewed the narrowing together, and the plan names them as responsible so that a broad start does not drift into a broad course.

What this page is doingDe-escalation is shown as a plan made on the first night and carried out when the result arrived. The note names the result, the change and the people responsible, which is what keeps a broad start from becoming a broad course.
4

Duration and the Stopping Date

For pneumococcal meningitis, treatment for 10 to 14 days is recommended (Tunkel et al., 2004), and 14 days is chosen here because he presented with reduced consciousness. The first dose was given at 11:40 p.m. on January 20, so the last dose will be given on the evening of February 3. Three findings would extend the course: fever or neurologic signs that fail to improve within 48 hours, which would prompt a repeat lumbar puncture and imaging; a complication such as a subdural empyema or brain abscess on imaging; or a later report that the isolate is less susceptible than first measured. Without one of these, ceftriaxone stops on February 3.

References

de Gans, J., & van de Beek, D. (2002). Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine, 347(20), 1549-1556. https://doi.org/10.1056/NEJMoa021334

Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004). Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases, 39(9), 1267-1284. https://doi.org/10.1086/425368

van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C. (2021). Community-acquired bacterial meningitis. The Lancet, 398(10306), 1171-1183. https://doi.org/10.1016/S0140-6736(21)00883-7

The NUR-635 Topic 2 assignment instructions

Topic 2 in NUR-635 asks students to write a rationale for antimicrobial selection. Strong papers name the infection, the likely organisms and the patient factors that shape the choice, then choose each agent against a coverage requirement rather than listing a regimen. Students should justify the dose and interval against the site of infection, since penetration into spaces such as cerebrospinal fluid demands higher doses, and state the route with the criteria for any switch. The rationale should describe de-escalation once cultures return, name a stopping date rather than a range, and cite current guidelines for each decision. Adjuncts that change outcomes, such as a corticosteroid given before the first antibiotic dose in some infections, belong in the rationale with their own evidence and timing.

How this NUR 635 Topic 2 example is built

The finished example reasons from the likely organism outward. The probable pathogens for this infection in this patient are named first, with local resistance considered where it is known, and the agent follows from that coverage rather than from familiarity. Spectrum is discussed as a cost: a broader agent buys certainty and pays in resistance and in collateral effect, and the example says which trade it is making. Dose is justified against the site of infection, since a drug reaching blood adequately may not reach bone or cerebrospinal fluid. Duration carries evidence, and the example names the day the course ends and what would extend it. De-escalation is planned in advance rather than left to chance.

Reading the NUR 635 Topic 2 rubric

Faculty reward each agent chosen for a named organism. An Excellent rationale names the likely organisms and starts ceftriaxone, vancomycin and ampicillin, with dexamethasone before the first dose, citing Tunkel and colleagues and de Gans and van de Beek. Credit goes to doses justified by penetration across the blood-brain barrier. The rubric values stating that no oral switch exists for this infection. Strong papers narrow therapy once pneumococcus grows at 36 hours, using van de Beek and colleagues. Top marks go to naming day 14 as the stopping date and saying why.

NUR 635 Topic 2 help: mistakes that cost marks

Prescriptions with no end date are the failure this topic addresses directly, and antimicrobial duration is the decision most often left open in student work. A second weakness is an agent chosen before the organisms are considered, which shows as a drug named in the first line with the coverage argument assembled afterward. Papers lose marks for reaching for broad coverage without acknowledging what it costs, since stewardship is part of the reasoning rather than a separate topic. Doses that ignore the site of infection produce technically correct prescriptions that would fail clinically. Omitting renal adjustment where the drug requires it is a safety error rather than an oversight. Agents chosen with no reference to local resistance patterns ignore the information most likely to matter.

Get an NUR-635 Topic 2 example written to your instructions

Send the NUR-635 Topic 2 instructions and the rubric from your classroom, with the infection and patient your section assigned. We write a custom example to those criteria, with likely organisms named first, spectrum treated as a cost, the dose justified against the site and a stopping date committed to, in 24 to 48 hours. The first is free.

More NUR 635 papers and MSN samples

NUR 635 Topic 2 questions, answered

How do I defend a duration rather than a range?

Pick a day and cite something. Many infections now have evidence supporting shorter courses than tradition uses, and naming the study or guideline behind your figure turns a habit into a decision. Then state what would extend it, such as a lack of clinical response by a defined point. A range with no commitment inside it is where most student prescriptions end, and it is what the topic is testing.

When is broad coverage justified?

When the patient is unstable, when the likely organisms genuinely span a wide range, or when missing coverage would be dangerous before cultures return. It is a legitimate choice with a stated cost. What makes it defensible is the plan attached: which result would narrow it, when that result is expected and who will act on it. Broad coverage without a de-escalation plan is the pattern stewardship programs exist to interrupt.

Why does the site of infection change the dose?

Because drugs distribute unevenly. An agent achieving adequate concentration in blood may reach very little into cerebrospinal fluid, bone, prostate or an abscess cavity, so the same infection in a different place needs a different dose or a different drug entirely. Stating the site and its penetration requirement is what separates a prescription that would work from one that is merely correct on paper.

Where can I find a free NUR 635 Topic 2 sample paper?

The rationale for NUR 635 Topic 2 covers the infection, organisms and patient, the agents chosen against coverage, dose and interval for the site, route, de-escalation after cultures and the stopping date. Share your NUR 635 Topic 2 prompt for a free paper.

Why give dexamethasone in NUR 635 Topic 2?

Because in adults with suspected pneumococcal meningitis, dexamethasone given with or before the first antibiotic dose reduced death and unfavorable outcomes in de Gans and van de Beek's trial.